SCHEMBL2246589

SCHEMBL2246589

OP(=S)(OCl)OCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1358818 0.79
SCHEMBL1149488 0.78
SCHEMBL7202962 0.73
SCHEMBL1290618 0.64
SCHEMBL2172258 0.61
SCHEMBL63347 0.61
SCHEMBL123364 0.61
SCHEMBL31364181 0.61 FDPS (0.50)
SCHEMBL992305 0.59 ALPG (0.31)
SCHEMBL277895 0.59 ALPG (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8999960-B2 Oxidized thiophospholipid compounds and uses thereof VASCULAR BIOGENICS LTD. (IL) 2015-04-07 US claimed
US-20110195937-A1 OXIDIZED THIOPHOSPHOLIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2011-08-11 US claimed
EP-2348864-A2 OXIDIZED THIOPHOSPHOLIPID COMPOUNDS AND USES THEREOF Vascular Biogenics Ltd. (IL) 2011-08-03 EP claimed
WO-2010041242-A2 OXIDIZED THIOPHOSPHOLIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2010-04-15 WO claimed
CN-115947758-A Nucleotide derivative and pharmaceutical composition and application thereof 南京知和医药科技有限公司 2023-04-11 CN disclosed
US-20230002424-A1 PROCESS FOR PREPARATION OF THIOPHOSPHORYL CHLORIDE AND ACEPHATE UPL LTD (IN) 2023-01-05 US disclosed
CN-115477696-A Albumin active polypeptide powder for improving hypodynamia symptoms and preparation method thereof 杭州佰倍优生物科技有限公司 2022-12-16 CN disclosed
EP-3089986-B1 CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE RXBIO INC (US) 2019-06-26 EP disclosed
US-20170226139-A1 CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE RXBIO INC (US) 2017-08-10 US disclosed
US-9567288-B2 Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate RXBIO, INC. (US) 2017-02-14 US disclosed
EP-3089986-A1 CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE Rxbio Inc. (US) 2016-11-09 EP disclosed
WO-2015102856-A1 CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE RXBIO INC. (US) 2015-07-09 WO disclosed
EP-0357048-A2 Process for transhalogenating a halophosphorus compound with hydrogen fluoride ALBEMARLE CORPORATION (US) 1990-03-07 EP disclosed
US-4904768-A Epipodophyllotoxin glucoside 4'-phosphate derivatives BRISTOL-MYERS COMPANY (US) 1990-02-27 US disclosed
EP-0353598-A2 Transhalogenation of halophosphorus compounds ETHYL CORPORATION (US) 1990-02-07 EP disclosed
EP-0312790-A2 Process for transhalogenating a halophosphorus compound with fluoride ETHYL CORPORATION (US) 1989-04-26 EP disclosed
EP-0302473-A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells Bristol-Myers Squibb Company (US) 1989-02-08 EP disclosed
EP-0234820-A2 A process for producing 0,0-dilower-alkylchlorothiophosphate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-09-02 EP disclosed
US-4322414-A MITICIDES; APHIDICIDES; LARVICIDES VELSICOL CHEMICAL CORPORATION (US) 1982-03-30 US disclosed
US-4309422-A INSECTICIDES VELSICOL CHEMICAL CORPORATION (US) 1982-01-05 US disclosed